Ectodysplasin A (EDA)

Ectodysplasin A (EDA) is a **type II transmembrane protein** and a member of the tumor necrosis factor (TNF) superfamily, encoded by the EDA gene on the X chromosome[1][2][6]. EDA is essential for the prenatal development of various **ectodermal derivatives**, including skin, hair, teeth, nails, and sweat glands, through its role in cell-cell signaling during embryogenesis[1][3][5][6]. The protein exists primarily as two functional splice variants, **EDA-A1 and EDA-A2**, which differ by two amino acids and bind distinct receptors (EDAR and EDA2R/XEDAR, respectively), both activating downstream NF-κB signaling pathways crucial for the morphogenesis and homeostasis of ectodermal organs[1][6]. Deficiency or mutation in EDA causes **X-linked hypohidrotic ectodermal dysplasia (XLHED)**, typified by sparse hair, abnormal teeth, and dysfunctional or absent sweat glands[1][2][3][5][6]. EDA is also emerging as a factor in metabolic disease and may act as a liver-secreted molecule, with elevated levels linked to conditions such as non-alcoholic fatty liver disease, obesity, and insulin resistance[1]. Beyond classic developmental disorders, EDA signaling has been explored in cancer biology and musculoskeletal diseases, although clinical targeting remains experimental[1].

Other names

Ectodysplasin-AEctodysplasin-A1Ectodysplasin-A2membrane form Ectodysplasin-Asecreted form Ectodysplasin-AED1EDA2EDA proteinEDA1XLHEDHEDXHEDED1-A1ED1-A2EDA-A1EDA-A2Ectodermal dysplasia proteinECTD1HED1ODT1STHAGX1TNLG7CX-linked anhidrotic ectodermal dysplasia proteinoligodontia 1tumor necrosis factor ligand 7C

Recombinant EDA1 acts as a ligand, binding to the Ectodysplasin A receptor (EDAR) to restore or enhance signaling in EDA-deficient individuals[1][2].